Doctor profile · Federal record
Dr. Sarah Barbre, NP
Nurse Practitioner · Huntsville, AL
- NPI 1477133221
- Accepts Medicare
- MIPS 76.3 / 100 · 2023
- 6 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3601 Cci Dr Nw
Huntsville, AL 358052606
(256) 705-4224 - Mailing address
-
Po Box 18428
Huntsville, AL 358048428
Credentials & registration
- NPI registered
- April 2021 — 5 yrs on file
- Profile last updated
- January 27, 2023
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Alabama #1-53466
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477133221. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
181
Distinct HCPCS
4
Medicare allowed
$16,767
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 120 | 113 | $93 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 33 | 33 | $138 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 17 | 17 | $60 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | 11 | $8 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 66. This provider delivers 2.7× the peer median.Open Payments
Industry payments received
All-time total
$1,466
Transactions
51
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $151.52 | |
| AstraZeneca Pharmaceuticals LP | 7 | $134.87 | |
| PFIZER INC. | 6 | $129.24 | |
| Daiichi Sankyo Inc. | 1 | $125.00 | |
| Merck Sharp & Dohme LLC | 4 | $110.38 | |
| Incyte Corporation | 5 | $100.20 | |
| Alexion Pharmaceuticals, Inc. | 3 | $69.27 | |
| Stemline Therapeutics Inc. | 2 | $64.77 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55.94 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50.37 | |
| Janssen Biotech, Inc. | 2 | $45.10 | |
| Lilly USA, LLC | 3 | $44.86 | |
| PharmaEssentia USA Corporation | 2 | $42.43 | |
| Genentech USA, Inc. | 2 | $40.72 | |
| BeiGene USA, Inc. | 2 | $38.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
37
Patients
0
Total drug cost
$16,874
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 13 | 0 | $273 |
| Eliquis (Apixaban) | Brand | 13 | 0 | $7,920 |
| Xarelto (Rivaroxaban) | Brand | 11 | 0 | $8,681 |
Frequently asked questions
What is Dr. Sarah Barbre's medical specialty?
Dr. Sarah Barbre practices Nurse Practitioner in Huntsville, AL.
Where does Dr. Sarah Barbre practice?
Dr. Sarah Barbre practices at 3601 Cci Dr Nw, Huntsville, AL 358052606. Office phone: 2567054224.
What is Dr. Sarah Barbre's NPI?
Dr. Sarah Barbre's National Provider Identifier (NPI) is 1477133221, issued by NPPES.
Does Dr. Sarah Barbre accept Medicare assignment?
Yes. Dr. Sarah Barbre accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sarah Barbre commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.